Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support

J Heart Lung Transplant. 2014 Jan;33(1):118. doi: 10.1016/j.healun.2013.07.015. Epub 2013 Aug 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Cardiomyopathies / therapy*
  • Follow-Up Studies
  • Fondaparinux
  • Heart Transplantation
  • Heart-Assist Devices / adverse effects*
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Polysaccharides / therapeutic use*
  • Thrombocytopenia / chemically induced*
  • Thrombosis / drug therapy
  • Thrombosis / prevention & control
  • Treatment Outcome

Substances

  • Anticoagulants
  • Polysaccharides
  • Heparin
  • Fondaparinux